Henry Schein (HSIC) Price Target Raised to $66.00

Share on StockTwits

Henry Schein (NASDAQ:HSIC) had its price objective hoisted by Morgan Stanley from $65.00 to $66.00 in a research note released on Tuesday. Morgan Stanley currently has an underweight rating on the stock.

Several other equities analysts have also weighed in on the company. BidaskClub raised Henry Schein from a buy rating to a strong-buy rating in a research note on Saturday, October 6th. ValuEngine raised Henry Schein from a sell rating to a hold rating in a research note on Saturday, October 6th. Zacks Investment Research raised Henry Schein from a hold rating to a buy rating and set a $98.00 target price on the stock in a research note on Friday, October 5th. Robert W. Baird increased their target price on Henry Schein from $90.00 to $95.00 and gave the company an outperform rating in a research note on Thursday, October 4th. Finally, Cleveland Research reissued a hold rating on shares of Henry Schein in a research note on Monday, September 24th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of Hold and an average price target of $83.83.

Henry Schein stock opened at $83.95 on Tuesday. The stock has a market capitalization of $13.02 billion, a P/E ratio of 23.33, a PEG ratio of 2.45 and a beta of 0.97. Henry Schein has a 12-month low of $62.56 and a 12-month high of $90.52. The company has a current ratio of 1.29, a quick ratio of 0.68 and a debt-to-equity ratio of 0.34.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Monday, August 6th. The company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.03. The business had revenue of $3.33 billion for the quarter, compared to analysts’ expectations of $3.31 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.15%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.88 earnings per share. As a group, equities analysts predict that Henry Schein will post 4.12 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bridge Creek Capital Management LLC grew its holdings in shares of Henry Schein by 2.1% during the third quarter. Bridge Creek Capital Management LLC now owns 34,947 shares of the company’s stock worth $2,971,000 after buying an additional 705 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Henry Schein by 57.1% during the second quarter. Fuller & Thaler Asset Management Inc. now owns 2,200 shares of the company’s stock worth $160,000 after buying an additional 800 shares in the last quarter. Kalos Management Inc. grew its holdings in shares of Henry Schein by 6.3% during the second quarter. Kalos Management Inc. now owns 13,615 shares of the company’s stock worth $988,000 after buying an additional 807 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its holdings in shares of Henry Schein by 1.8% during the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 46,794 shares of the company’s stock worth $3,399,000 after buying an additional 846 shares in the last quarter. Finally, GHP Investment Advisors Inc. grew its holdings in shares of Henry Schein by 9.8% during the second quarter. GHP Investment Advisors Inc. now owns 10,465 shares of the company’s stock worth $760,000 after buying an additional 930 shares in the last quarter. 96.65% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading: Stock Symbol

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply